Trial Profile
Idelalisib: - a pharmacokinetic profile
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2015
Price :
$35
*
At a glance
- Drugs Idelalisib (Primary)
- Indications Chronic lymphocytic leukaemia; Non-Hodgkin's lymphoma
- Focus Pharmacokinetics
- Sponsors Gilead Sciences
- 12 Nov 2015 New trial record